Participation of Tenascin C in Native and Homograft Aortic Valve Degeneration

被引:0
|
作者
Lis, Grzegorz J. [1 ]
Jasek, Ewa [1 ]
Gajda, Mariusz [1 ]
Litwin, Jan A. [1 ]
Czubek, Urszula [2 ]
Jasinska, Malgorzata [1 ]
Kapelak, Boguslaw [3 ]
Sadowski, Jerzy [3 ]
机构
[1] Jagiellonian Univ, Coll Med, Chair & Dept Histol, PL-31034 Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Coronary Dis, PL-31034 Krakow, Poland
[3] Jagiellonian Univ, Coll Med, Dept Cardiac & Vasc Surg & Transplantol, PL-31034 Krakow, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2011年 / 20卷 / 02期
关键词
tenascin; aortic valve; homograft; extracellular matrix proteins; immunofluorescence; WARM ISCHEMIA; HEART-VALVES; DISEASE; VIABILITY; BONE; ALLOGRAFTS; EXPRESSION;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Tenascin C (TnC) is a connective tissue matrix glycoprotein influencing cell proliferaton, migration and apoptosis. TnC participates in the development of pathological processes in the circulatory system including, as recently demonstrated, valvular degeneration leading to aortic valve stenosis. Homograft durability is limited by its degeneration, similar to changes appearing in cases of a typical aortic stenosis, which currently are regarded as an active remodeling process with expression of inflammatory modulators, as well as participation of cells and extracellular factors (including TnC), which under physiological conditions are involved in bone formation. Objectives. The aim of the study was a comparison of TnC expression in native stenotic aortic valves and degenerating aortic valve homografts. Material and Methods. The material included two groups of aortic valves removed during routine surgery: native stenotic valves (n = 10) and dysfunctional aortic valve homografts (n = 10). Frozen valve sections were used for immunohistochemical detection of TnC, and also for identification of cells differentiated towards myofibroblasts (SMA), macrophages (CD68) and endothelial cells (CD34, vWF). Results. TnC immunoreactivity was observed in both valve types, being significantly higher in native stenotic valves than in homografts (p = 0.007). The proportion of myofibroblasts in the total valvular cell population was insignificantly higher in native valves than in homografts. In homografts showing significantly lower total celullarity than native valves (p = 0.003), macrophages were more numerous (p = 0.005), and located mostly on the valve leaflet surfaces, while in native valves they were almost absent in this location. Conclusions. The presence of TnC in the stroma of native stenotic aortic valves and in homografts indicates a participation of active remodeling mechanisms in the pathogenesis of degeneration in both types of valves. However, a significantly lower level of TnC and lower cellularity in homografts suggests that changes leading to their dysfunction, to some extent, include passive degeneration (Adv Clin Exp Med 2011, 20, 2, 157-164).
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [2] Aortic valved homograft degeneration: surgical or transcatheter approach for repeat aortic valve replacement?
    Peterss, Sven
    Fabry, Thomas G.
    Steffen, Julius
    Orban, Martin
    Buech, Joscha
    Radner, Caroline
    Theiss, Hans D.
    Pichlmaier, Maximilian
    Massberg, Steffen
    Hagl, Christian
    Deseive, Simon
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2024, 66 (01)
  • [3] Native Aortic Valve Disease Progression and Bioprosthetic Valve Degeneration in Patients With Transcatheter Aortic Valve Implantation
    Kwiecinski, Jacek
    Tzolos, Evangelos
    Cartlidge, Timothy R. G.
    Fletcher, Alexander
    Doris, Mhairi K.
    Bing, Rong
    Tarkin, Jason M.
    Seidman, Michael A.
    Gulsin, Gaurav S.
    Cruden, Nicholas L.
    Barton, Anna K.
    Uren, Neal G.
    Williams, Michelle C.
    van Beek, Edwin J. R.
    Leipsic, Jonathon
    Dey, Damini
    Makkar, Raj R.
    Slomka, Piotr J.
    Rudd, James H. F.
    Newby, David E.
    Sellers, Stephanie L.
    Berman, Daniel S.
    Dweck, Marc R.
    CIRCULATION, 2021, 144 (17) : 1396 - 1408
  • [4] HOMOGRAFT AORTIC-VALVE AND ROOT REPLACEMENT FOR SEVERE DESTRUCTIVE NATIVE OR PROSTHETIC ENDOCARDITIS
    PAGANO, D
    ALLEN, SM
    BONSER, RS
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1994, 8 (04) : 173 - 176
  • [5] Aortic valve homograft regurgitation: Perivalvular or not?
    Ericksen, ML
    Vezina, DP
    Peragallo, RA
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2003, 17 (01) : 134 - 135
  • [6] Sutureless Perceval Aortic Valve Replacement in Aortic Homograft
    Folliguet, Thierry A.
    Laborde, Francois
    ANNALS OF THORACIC SURGERY, 2013, 96 (05) : 1866 - 1868
  • [7] Aortic root homograft in the surgical treatment of aortic valve disease with dilated ascending aorta
    Pinto, AG
    Vázquez, RJ
    Sánchez, A
    Roda, JR
    Badorrey, V
    Vilacosta, I
    Parra, J
    Delcán, JL
    Medina, J
    Sancho, M
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (05): : 412 - 416
  • [8] Valve failure following homograft aortic valve replacement: does implantation technique have an effect?
    Ali, Ayyaz
    Abu-Omar, Yasir
    Patel, Amit
    Ali, Ziad
    Sheikh, Ahmad Y.
    Akhtar, Asim
    Pavlovic, Aleksandra
    Theodorou, Panagiotis
    Athanasiou, Thanos
    Pepper, John
    EUROPEAN HEART JOURNAL, 2008, 29 (11) : 1454 - 1462
  • [9] TAVI-in-homograft (TiH): open transcatheter aortic valve replacement in calcified aortic homograft case reports
    Marco Gennari
    Ilaria Giambuzzi
    Gianluca Polvani
    Marco Agrifoglio
    Journal of Cardiothoracic Surgery, 14
  • [10] TAVI-in-homograft (TiH): open transcatheter aortic valve replacement in calcified aortic homograft case reports
    Gennari, Marco
    Giambuzzi, Ilaria
    Polvani, Gianluca
    Agrifoglio, Marco
    JOURNAL OF CARDIOTHORACIC SURGERY, 2019, 14 (01)